Health product recall

PMS-Duloxetine 30 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)

Last updated

Summary

Product
PMS-Duloxetine 30 mg
Issue
Health products - Product quality
What to do

Consult your health care professional if you have any health concerns. 

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

PMS-Duloxetine

PMS-Duloxetine 30 mg - 100 capsules

DIN 02429446

Capsule (Delayed Release)

Duloxetine (Duloxetine Hydrochloride) 30 mg

646038

Issue

Affected lot exceeds the interim acceptable intake limit for N-nitroso-duloxetine (NDLX).

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Pharmascience Inc.

6111, av. Royalmount, Suite 100

Montréal, Québec H4P 2T4

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-75397

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe